Call for Concept Proposals for 2023 NIH CFAR Ending the HIV Epidemic Supplement-Funded Research Projects

Call for Concept Proposals for 2023 NIH CFAR Ending the HIV Epidemic Supplement-Funded Research Projects

NOTICE OF SPECIAL INTEREST (NOSI): 2023 NIH CFAR Ending the HIV Epidemic Supplements 

The Center for AIDS Research (CFAR) at Emory University is soliciting concept proposals for supplemental grant applications in response to the 2023 NIH CFAR Ending the HIV Epidemic Funding Opportunity. CFAR Ending the HIV Epidemic (EHE) Supplements are up to $150,000 (direct cost) per year for up to two years. Proposals must be in response to one of the following four topics:

EHE Scientific Topics for 2023:

1. Syndemic Approaches to HIV Prevention, Treatment or Care:

  • using syndemic theory and approaches to (a) increase focus on intersecting diseases and social conditions that exacerbate health inequities, and (b) enhance the evidence base for effective successful approaches to assess, monitor, and intervene with respect to these intersections for optimal outcomes in HIV prevention or treatment

2. Leveraging Pharmacies to Advance HIV Testing, Prevention, and Care:

  • research projects designed to further capacitate, field, and scale the routine delivery of HIV testing, prevention, and care services through pharmacists and pharmacy settings in the U.S.

3. Strategies to Improve Linkage to HIV Care and Services Post-Incarceration:

  • improving linkage and connection to mental health, substance use, social services, housing, job services, HIV care, and any other community resources post-incarceration; The goals are to optimize timely linkage to HIV care, retention, and viral suppression among people living with HIV (PLWH) re-entering their communities.

4. Cluster Detection and Response Strategies:

  • using cluster detection and response strategies to address identified service gaps, reduce HIV-related health disparities, and contain outbreaks

MORE INFORMATION ON THESE TOPICS CAN BE FOUND IN THE NIH CFAR NOSI LINKED AT THE BOTTOM OF THIS PAGE.

Applicants must meet the following eligibility criteria.

ELIGIBILITY:

  • Faculty or faculty-equivalent position with a full-time appointment at Emory University as of award start date (anticipated June 1, 2023);
  • And, eligibility to be PI on an NIH R-level grant

IMPLEMENTING PARTNER REQUIREMENT:

Applicants must collaborate with an implementing partner(s) located in one of 57 priority jurisdictions for EHE.  Implementing partners can include community, local, county and state health departments, community-based organizations, and clinics receiving funds from the CDC, HRSA, SAMHSA, or IHS.  NIH CFAR EHE Supplement reserach projects should be developed by a team of CFAR investigators, community partners, implementing partners, and people with lived experience to support the local ending the HIV epidemic plans.

DEADLINE FOR SUBMISSION: February 3, 2023 by MIDNIGHT EST

APPLICATION PROCESS

Interested applicants must complete THIS ONLINE FORM to submit their one-page concept proposals as a single PDF document by midnight EST on Friday, February 3, 2023.

Concept proposal PDFs must include the following:

1. brief scientific rationale

2. proposed specific aims

3. relevance to the CFAR EHE Supplement scientific topic selected (see 1-4 above)

4. proposal’s potential to impact local EHE efforts

The CFAR Leadership will review submitted applications to select those which will be invited to submit a full application to NIH. A member of the Emory CFAR Administrative Core will contact all applicants by February 10th regarding the review outcome and to support those who were seelected to move forward in the appication process.

Please contact Shelle Bryant (sbryant@emory.edu) with any questions regarding this process.

Emory CFAR at ID Week 2022

Emory CFAR at ID Week 2022

Emory University at ID Week 2022

Emory University is well-represented at the ID Week 2022 conference with 47 presentations — 24 talks or panels and 23 posters — featuring Emory faculty, students, and staff.  Please use the full spreadsheet of presentations below as a  guide to support your fellow Emory CFAR Members by tuning in for their sessions and Q&A.  We also invite you to follow along with us on Twitter (@EmoryCFAR) for daily tweets featuring Emory CFAR Member-led and/or HIV-related presentations!

Kudos to the conference planning committee, including Emory CFAR Members, Carlos del Rio, Colleen Kelley, and Nadine Rouphael on an exciting line-up.

On behalf of the Emory CFAR, congratulations to all of you who are representing Emory at #IDWeek2022!

Emory CFAR Members Receive R01 from NIH NIDCR to Accelerate Search for Novel Biomarkers for Oral HPV Infection Among People Living with HIV

Emory CFAR Members Receive R01 from NIH NIDCR to Accelerate Search for Novel Biomarkers for Oral HPV Infection Among People Living with HIV

Emory University is awarded 3.9 million ($3,930,416 from 2022 to 2027) from the National Institutes of Health (NIH, NIDCR) for a new R01 to accelerate the search for novel biomarkers for oral human papillomavirus (HPV) infection among people living with HIV. The principal investigators, Canhua Xiao, PhD, RN, FAAN is an Associate professor in the School of Nursing, and Lisa Flowers, MD, MPH is a Professor in the Department of Obstetrics and Gynecology, Emory University School of Medicine.

HPV infection has been identified as a definite human carcinogen for oropharyngeal cancer.  People living with HIV (PLWH) have a much higher rate of oral HPV infection and oropharyngeal cancer than the general population.  Yet, the etiology and pathophysiology of oral HPV infection in PWH are not well-documented. Therefore, the collaboratory team will examine the associations among oral microbiome, periodontal diseases, and oral HPV infection.  In addition, the team to identify and harness the unique immunological underpinnings of oral HPV infection in people with HIV.  The immunological analysis of this study will be conducted by the study Co-investigator Vijayakumar Velu, PhD an immunologist, Assistant Professor from Emory Vaccine Center and Emory National Primate Center. Other Co-investigators are Drs. David Reznik, Deborah Bruner, Sudeshna Paul, Timonthy D. Read, Minh Ly T. Nguyen, Terryl Hartman, Elizabeth Unger, and Gypsyamber D’Souza.  The findings may indicate new biomarkers and novel therapeutic targets for preventing and managing oral HPV infection.

 

The study leaders are (left to right) Canhua Xiao, PhD, RN, FAAN; Lisa Flowers, MD, MPH; and Vijayakumar Velu, PhD.

Call for Proposals that Address the Intersection of HIV and the Monkeypox Virus

Call for Proposals that Address the Intersection of HIV and the Monkeypox Virus

NOTICE OF SPECIAL INTEREST (NOSI): 2023 NIH CFAR Ending the HIV Epidemic Supplements 

The Center for AIDS Research (CFAR) at Emory University is soliciting concept proposals for supplemental grant applications in response to the 2023 NIH CFAR Ending the HIV Epidemic Funding Opportunity. CFAR Ending the HIV Epidemic (EHE) Supplements are up to $150,000 (direct cost) per year for up to two years. Proposals must be in response to one of the following four topics:

EHE Scientific Topics for 2023:

  1. Syndemic Approaches to HIV Prevention, Treatment or Care:
    • using syndemic theory and approaches to (a) increase focus on intersecting diseases and social conditions that exacerbate health inequities, and (b) enhance the evidence base for effective successful approaches to assess, monitor, and intervene with respect to these intersections for optimal outcomes in HIV prevention or treatment
  2. Leveraging Pharmacies to Advance HIV Testing, Prevention, and Care:
    • research projects designed to further capacitate, field, and scale the routine delivery of HIV testing, prevention, and care services through pharmacists and pharmacy settings in the U.S.
  3. Strategies to Improve Linkage to HIV Care and Services Post-Incarceration:
    • improving linkage and connection to mental health, substance use, social services, housing, job services, HIV care, and any other community resources post-incarceration; The goals are to optimize timely linkage to HIV care, retention, and viral suppression among people living with HIV (PLWH) re-entering their communities.
  4. Cluster Detection and Response Strategies:
    • using cluster detection and response strategies to address identified service gaps, reduce HIV-related health disparities, and contain outbreaks

MORE INFORMATION ON THESE TOPICS CAN BE FOUND IN THE NIH CFAR NOSI LINKED AT THE BOTTOM OF THIS PAGE.

Applicants must be current Emory faculty or faculty-equivalent who meet the following eligibility criteria.

ELIGIBILITY:

  • Eligibility to be PI on an NIH R-level grant
  • Faculty or faculty-equivalent position with a full-time appointment at Emory University as of award start date (anticipated June 1, 2023).
  • Meets the definition of an NIH “New Investigator” in HIV/AIDS. Specifically, prior funding as an NIH independent investigator makes an applicant ineligible ONLY IF the funding has been in the HIV field.
    • Exception: Investigators with prior independent NIH funding in HIV are eligible if they have not been the PI on any NIH HIV-related grant within the last five years.

DEADLINE FOR SUBMISSION: February 3, 2023 by MIDNIGHT EST

APPLICATION PROCESS

Interesetd applicants must complete THIS ONLINE FORM to submit their one-page concept proposals as a single PDF document by midnight EST on Friday, February 3, 2023.

Concept proposal PDFs must include the following:

  1. brief scientific rationale
  2. proposed specific aims
  3. relevance to the CFAR EHE Supplement topic selected (see 1-4 above)
  4. proposal’s potential to impact local EHE efforts

The CFAR Leadership will review submitted applications to select those which will be invited to submit a full application to NIH. A member of the Emory CFAR Administrative Core will contact all applicants by February 10th regarding the review outcome and to support those who were seelected to move forward in the appication process.

Please contact Shelle Bryant (sbryant@emory.edu) with any questions regarding this process.

Call for Applications for the Emory Training Program in HIV Translational Research to End the Epidemic

Call for Applications for the Emory Training Program in HIV Translational Research to End the Epidemic

TRAINING OPPORTUNITY: Fellow-driven & mentor-supported HIV translational research fellowships at Emory University

Are you a PhD, MD, MD/PhD graduate with an interest in HIV Translational Research? Are you within seven years of your terminal degree? Are you a U.S. Citizen or Naturalized (Green Card) U.S. Citizen? Can you devote two years to training?

All trainees must commit full-time effort to the program and its related research activities.

Eligible Areas of HIV Research

  • Laboratory-based science, vaccine, and cure research
  • Patient-centered clinical research
  • Public health and implementation science

Trainees will gain expertise in cross-cutting areas ofscience and translation to the Ending the HIV Epidemic Initiative

HIV T32 Program Trainees will Receive:

  • Annual stipend at appropriate NIH-specifiedlevel based on years of postdoc experience
  • Travel & childcare allotments; research supplies
  • Tuition support for formal didactic training intranslational research (MSCR, CPTR, or selectedgraduate level courses)
  • Hands-on translational research rotation

DEADLINE FOR SUBMISSION: April 15, 2022

Application Process:

1. Potential candidates should complete an HIV T32 Interest Form to initiate discussion with the faculty Program Director (PD) in the target area of interest regarding the candidate application: https://bit.ly/EmoryHIVT32

a. Laboratory-based basic science, vaccine, and cure research: Ann Chahroudi, MD, PhD
b. Patient-centered clinical research: Colleen Kelley, MD, MPH
c. Public health and implementation science: Patrick Sullivan, DVM, PhD

2. Applicants will identify potential mentor(s) from the list below during the discussion with the faculty PD. The PD will then contact the mentor(s) suggested to confirm willingness to meet with the applicant.

3.  The Program Coordinator will then connect applicants and potential mentors. It is up to the applicant/mentor to meet and mutually decide the best fit. Once the mentor has agreed to support the trainee throughout the duration of the appointment, the applicant must notify the Program Coordinator via email of final decision.

4.  Approval to apply should be obtained prior to April 1, 2022. Candidates are encouraged to apply after mentor and program reviews are

To apply, submit an application package including the following documents as a single PDF via email to deaunna.thomas@emory.edu by 5 PM EST on April 15, 2022:

  • Cover letter specifying focus area of interest with statement of future goals for a career in HIV research. Applicants should include personal qualifications for the fellowship and what they hope to gain from the fellowship;
  • Current CV or NIH biosketch;
  • A letter of support from the proposed HIV T32 mentor;
  • Letter(s) of support from one other scientist (e.g. recent supervisor, mentor, or a collaborator);
  • A two-page description of the proposed research project and proposed didactic training plan (including graphs/figures but not references);
  • MD applicants from clinical departments must also provide a letter from the applicant’s Department/Division Chair, indicating departmental commitment to provide at least 75% protected time for the trainee applicant to devote to the proposed research project. This letter can be same as the required letter of support from one other scientist, described above.